Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Lexaria Bioscience Corp.

    NASDAQ: LEXX · Real-Time Price · USD
    0.84
    -0.01 (-1.06%)
    At close: Aug 20, 2025, 9:37 AM

    Lexaria Bioscience Income Statement

    Financials in USD. Fiscal year is September - August.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Aug 31, 2024 Aug 31, 2023 Aug 31, 2022 Aug 31, 2021
    Revenue
    		 464.28K 226.21K 255.4K 722.74K
    Cost of Revenue
    		 4.82K 31.5K 71.84K 175.35K
    Gross Profit
    		 459.46K 194.71K 183.56K 547.39K
    Operating Income
    		 -5.75M -6.53M -7.38M -5.69M
    Interest Income
    		 14.31K 43.19K n/a n/a
    Pretax Income
    		 -5.81M -6.71M -7.38M -4.16M
    Net Income
    		 -5.8M -6.66M -7.27M -2.5M
    Selling & General & Admin
    		 3.85M 3.06M 5.72M 4.97M
    Research & Development
    		 2.36M 3.67M 1.84M 1.26M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 6.21M 6.73M 7.57M 6.23M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 6.22M 6.76M 7.64M 6.41M
    Income Tax Expense
    		 n/a n/a -114.33K -1.66M
    Shares Outstanding (Basic)
    		 12.38M 6.61M 5.89M 4.39M
    Shares Outstanding (Diluted)
    		 12.38M 6.61M 5.89M 4.39M
    EPS (Basic)
    		 -0.47 -1.01 -1.24 -0.57
    EPS (Diluted)
    		 -0.47 -1.01 -1.24 -0.57
    EBITDA
    		 -5.68M -6.39M -6.52M -5.58M
    EBIT
    		 -5.75M -6.53M -6.62M -5.69M
    Depreciation & Amortization
    		 76.15K 145.4K 146.91K 147.6K

    Add to Watchlist